We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Align Technology (ALGN) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
Align Technology (ALGN - Free Report) closed the most recent trading day at $307.66, moving +0.42% from the previous trading session. The stock lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added 1.02%, and the tech-heavy Nasdaq gained 1.66%.
Coming into today, shares of the maker of the Invisalign tooth-straightening system had lost 5.23% in the past month. In that same time, the Medical sector lost 1.73%, while the S&P 500 lost 2.76%.
ALGN will be looking to display strength as it nears its next earnings release. On that day, ALGN is projected to report earnings of $1.51 per share, which would represent year-over-year growth of 16.15%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $595.61 million, up 21.49% from the year-ago period.
ALGN's full-year Zacks Consensus Estimates are calling for earnings of $5.49 per share and revenue of $2.44 billion. These results would represent year-over-year changes of +11.59% and +24.16%, respectively.
Investors might also notice recent changes to analyst estimates for ALGN. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. ALGN currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, ALGN is holding a Forward P/E ratio of 55.76. Its industry sports an average Forward P/E of 21.73, so we one might conclude that ALGN is trading at a premium comparatively.
Meanwhile, ALGN's PEG ratio is currently 2.38. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 2.23 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 52, putting it in the top 21% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Align Technology (ALGN) Gains But Lags Market: What You Should Know
Align Technology (ALGN - Free Report) closed the most recent trading day at $307.66, moving +0.42% from the previous trading session. The stock lagged the S&P 500's daily gain of 1.05%. At the same time, the Dow added 1.02%, and the tech-heavy Nasdaq gained 1.66%.
Coming into today, shares of the maker of the Invisalign tooth-straightening system had lost 5.23% in the past month. In that same time, the Medical sector lost 1.73%, while the S&P 500 lost 2.76%.
ALGN will be looking to display strength as it nears its next earnings release. On that day, ALGN is projected to report earnings of $1.51 per share, which would represent year-over-year growth of 16.15%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $595.61 million, up 21.49% from the year-ago period.
ALGN's full-year Zacks Consensus Estimates are calling for earnings of $5.49 per share and revenue of $2.44 billion. These results would represent year-over-year changes of +11.59% and +24.16%, respectively.
Investors might also notice recent changes to analyst estimates for ALGN. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. ALGN currently has a Zacks Rank of #3 (Hold).
Looking at its valuation, ALGN is holding a Forward P/E ratio of 55.76. Its industry sports an average Forward P/E of 21.73, so we one might conclude that ALGN is trading at a premium comparatively.
Meanwhile, ALGN's PEG ratio is currently 2.38. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 2.23 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 52, putting it in the top 21% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.